The Philippine Economic Zone Authority (PEZA) has registered a P1.2 billion investment by Zen LifeSciences Inc. to produce pharmaceutical products and strengthen the country’s role in global health supply chains.
Under a registration agreement signed by PEZA director-general Tereso Panga and Zen LifeSciences president Maximo Ponce Balajadia, the company will manufacture medical, wellness and general health care products. The facility will be located at the Luisita Industrial Park–Special Economic Zone in Tarlac.
The project marks the first pharmaceutical economic zone in the Philippines. It is designed to host facilities certified by the US Food and Drug Administration and will include the production of active pharmaceutical ingredients.
Commercial operations are scheduled to begin in January 2027. The venture is expected to provide jobs for 90 Filipinos in manufacturing and support roles.
The investment aligns with a broader PEZA strategy to establish dedicated “pharma ecozones.” These zones aim to attract international drug makers and increase domestic production to reduce the country’s dependence on imported medicines.
